miR-26a is a well conserved miRNA whose overexpression or inhibition has been implicated in the pathogenesis of multiple disease, including obesity associated comorbidities such as reduced insulin sensitivity (Xu et al., 2020) and atherosclerosis (Feng et al., 2018). The gene discussed is INS; the disease is obesity disorder.